Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia

This study is currently recruiting participants.
Verified March 2012 by University of South Florida
Sponsor:
Collaborator:
Baxter Healthcare Corporation
Information provided by (Responsible Party):
Theresa Zesiewicz, University of South Florida
ClinicalTrials.gov Identifier:
NCT01350440
First received: April 20, 2011
Last updated: March 26, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)